CHEMICAL/BIOLOGICAL DEFENSE (ATD)
Abstract
Demonstrates technologies supporting transition to advanced component development. This includes physical capabilities which cover biological and chemical detection, situational awareness and effects modeling, and protection and hazard mitigation. Other major efforts support enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for biosurveillance in pathogen detection and diagnosis, and pretreatments and therapeutics against a broader set of chemical and biological agents. Medical capabilities (pretreatments, therapeutics, diagnostics capabilities, and drug manufacturing and regulatory science technologies), include capabilities against non-traditional agents. In the physical sciences area, Project CB3 focuses on demonstrations of CB defense technologies, including biological detection, chemical detection, information system technology for hazard prediction and systems performance, and protection, and decontamination. The Project continues to pursue solutions against traditional agents. All non-traditional agent (NTA)-dedicated research (both medical and non-medical) is consolidated in Project NT3. This Project includes NTA chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. The medical program in Project TM3, aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. Project TT3, Techbase Technology Transition, pursues efforts to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack. One function of the CBDP S&T Advanced Technology Development budget is to preserve critical core competencies in the DoD Service laboratories which includes: United States Army Edgewood Chemical Biological Center (ECBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. The PE is dedicated to conducting proof-of-principle field demonstrations, and testing system-specific technologies to meet specific military needs. Work conducted under this PE will transition to and will provide risk reduction for PE 0603884BP/PE 0604384BP activities.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2019
- Source ID
- 0603384BP_3_0400_PB_2019
- Change Summary Explanation
- Funding: FY17 (+$5.000M): Congressional add to Medical Biological Pretreatments (TM3). FY17 (-$1.099M): Program reprogrammings to support high priority CBDP efforts to include Advanced Development and Manufacturing Antibody Technologies. FY17 (-$1.809M): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY19 (-$0.902M): Application of revised inflation guidance. FY19 (+$2.000M): Program adjustments to balance overall portfolio efforts. Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (ATD)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Percutaneous Protection
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Biosurveillance (BSV)
- Child Accomplishment: 6) Detection
- Child Accomplishment: 7) Hazard Prediction
- Child Accomplishment: 8) Data Analysis
- Child Accomplishment: 9) Operational Effects
- Child Accomplishment: 10) Threat Surveillance
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (ATD)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Personnel Contamination Mitigation
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Pretreatments - Medical
- Child Accomplishment: 6) Therapeutics - Medical
- Child Accomplishment: 7) Detection
- Child Accomplishment: 8) Modeling & Simulation
- Child Accomplishment: 9) Percutaneous Protection
- Child Accomplishment: 10) Test & Evaluation
- Child Project: TECHBASE MED DEFENSE (ATD)
- Child Accomplishment: 1) Assays and Reagents
- Child Accomplishment: 2) Bacterial Therapeutics
- Child Accomplishment: 3) Bacterial/Toxin Vaccines
- Child Accomplishment: 4) Biosurveillance (BSV)
- Child Accomplishment: 5) Diagnostic Device Platforms
- Child Accomplishment: 6) Neurologic Therapeutics
- Child Accomplishment: 7) Vaccine Platforms and Research Tools
- Child Accomplishment: 8) Viral Therapeutics
- Child Accomplishment: 9) Viral Vaccines
- Child Accomplishment: 10) Medical Diagnostics
- Child Project: TECHBASE TECHNOLOGY TRANSITION
- Child Accomplishment: 1) Experiment & Technology Demonstrations